Moderate GSK-3β inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy.

Hoang MV, Smith LE, Senger DR.
Angiogenesis. 2010 Sep;13(3):269-77. doi: 10.1007/s10456-010-9184-y. Epub 2010 Sep 1.